Flagship Harbor Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
ASN
CCP
NAM
RJA
WIA
Flagship Harbor Advisors's SBIO Position: Q1 2019 in Review
Flagship Harbor Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 140 shares — an estimated $3K sold.
Flagship Harbor Advisors first reported a position in SBIO in Q2 2018 and held it in 3 quarters. The position peaked at $15K in Q2 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.
- Flagship Harbor Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
- Flagship Harbor Advisors sold 140 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $3K.
- Flagship Harbor Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q2 2018 and held it in 3 quarters.
- Flagship Harbor Advisors's ALPS Medical Breakthroughs ETF position peaked at $15K in Q2 2018.
- 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.
Based on Flagship Harbor Advisors's 13F filing for Q1 2019, filed 15 Apr 2019.